Published on: Nov 16, 2017 at https://www.prnewswire.com/news-releases/first-gastric-cancer-patient-dosed-in-clinical-trial-collaboration-evaluating-halozymes-pegph20-in-combination-with-anti-pdl1-immunotherapy-300541741.html

First Gastric Cancer Patient Dosed In Clinical Trial Collaboration Evaluating Halozyme’s PEGPH20 In Combination With Anti-PDL1 Immunotherapy

By : https://www.prnewswire.com/news-releases/first-gastric-cancer-patient-dosed-in-clinical-trial-collaboration-evaluating-halozymes-pegph20-in-combination-with-anti-pdl1-immunotherapy-300541741.html

The first gastric cancer patient is receiving doses in the clinical trial collaboration evaluating Halozyme’s PEGPH20 with anti-PDL1 immunotherapy.

Read More
SHARE